SOURCE: Ingen Technologies, Inc.
RIVERSIDE, CA--(Marketwired - Dec 30, 2013) - Ingen Technologies Inc. (PINKSHEETS: IGNT) (http://ingen-tech.com), the holding company of two subsidiaries; a medical device manufacturing company selling its patented medical products worldwide, and a newly acquired growing wireless telecom business providing services to major telecom companies worldwide, announced the results of the shareholder conference held on December 16th, 2013.
The major highlight of the shareholder teleconference was the approval to accept the option of taking the company to the OTCQB. Gary Tilden, Chairman, and David Hanson, Director conducted the shareholder meeting.
More recently, the company is also strongly considering a listing on the American Stock Exchange (AMEX) pursuant to discussions and the evaluation of a Memorandum of Understanding with Benchmark Advisory Partners.
"This teleconference was an opportunity to reach out to our shareholders and investors to discuss specific changes that, over time, will create better liquidity and exposure of Ingen. The company has resolved the majority of its debt issues, as well as being in the process of removing the DTCC 'CHILL' on its stock," stated Gary Tilden, Chairman. Mr. Tilden further stated, "Both of our subsidiaries are in profitable market sectors with growing industry economics, where increased revenues are beginning to become apparent. This growth should result in stronger shareholder value for our current and future shareholders. The move to the OTCQB or AMEX will only enhance the progress already being made."
Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.